-+ 0.00%
-+ 0.00%
-+ 0.00%

NUVECTIS PHARMA - NXP200 GRANTED BREAKTHROUGH THERAPY DESIGNATION BY CHINA CDE FOR BRAF V600-MUTANT GLIOMA

Reuters·09/24/2026 12:04:14